Tarsus Pharmaceuticals (TARS US)

Analysis

Health Care • United States

Tarsus Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company develops drugs and therapies for treatment of blepharitis. Tarsus Pharmaceuticals serves patients in the United States.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00